Modern and me have announced promising results from new vaccines
to help fight skin cancer. At a conference.
Yesterday, researchers said patients who received their M R
N A vaccine had a 44% reduction in cancer recurrence
or death. Researchers say 79% of participants who received
the vaccine stayed free for 18 months. Both companies
say there were only mild side effects. The companies
are working with us regulators on a late stage trial
before the end of the year. Meanwhile, Merck
yesterday announcing it would buy pro Biosciences for almost$11 00:00:35.450 --> billion.